compound 5 [PMID: 30894487]   

GtoPdb Ligand ID: 10398

Compound class: Synthetic organic
Comment: Compound 5 is the lead identified from a target-based approach to develop new compounds with antimalarial activity [1].

The Malaria tab on this ligand page provides additional curator comments of relevance to the Guide to MALARIA PHARMACOLOGY.
2D Structure
Click here for structure editor
Physico-chemical Properties
Hydrogen bond acceptors 3
Hydrogen bond donors 2
Rotatable bonds 4
Topological polar surface area 79.54
Molecular weight 355.1
XLogP 3.64
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Canonical SMILES Fc1ccc2c(c1)c(=O)cc(o2)C(=O)NCC1(O)CCC(CC1)(F)F
Isomeric SMILES Fc1ccc2c(c1)c(=O)cc(o2)C(=O)NCC1(O)CCC(CC1)(F)F
InChI InChI=1S/C17H16F3NO4/c18-10-1-2-13-11(7-10)12(22)8-14(25-13)15(23)21-9-16(24)3-5-17(19,20)6-4-16/h1-2,7-8,24H,3-6,9H2,(H,21,23)
InChI Key PJBRCGHQNUWERQ-UHFFFAOYSA-N
Guide to Malaria Pharmacology Comments
Compound 5 was optimized, using a structure-based aproach, from the small molecule hit identified from a series of selective inhibitors of apicomplexan lysine--tRNA ligase (lysyl-tRNA synthetase) [1]. Plasmodium lysine--tRNA ligase (PfKRS1) has been validated as a target for antimalarial drug development when it was shown to be the target of the natural product cladosporin [2].